AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

5 Capped MRNA Encoding Full Length SARS-COV-2 Spike Protein

9 registrations across 1 African market— 0 active

Markets with 5 Capped MRNA Encoding Full Length SARS-COV-2 Spike Protein

Recent registrations

Brand / ProductMarketHolderStatusExpires
Pfizer-BioNtech COVID-19VaccineBivalent(Original and Omicron BA.4/BA.5
Suspension injectable / 30 µg
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredNov 2022
COMINARTY
Suspension injectable / 10 µg
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredSept 2022
COMINARTY
Suspension injectable / 10 µg
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredSept 2022
COMIRNATY (Tri/Sucrose)
Suspension injectable / 30 µg /0.3ml
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredSept 2022
Pfizer-BioNtech COVID-19 Vaccine
Suspension injectable / 30 µg
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredDec 2021
Pfizer-BioNtech COVID-19 Vaccine
Suspension injectable / 30 µg
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredDec 2021
Pfizer-BioNtech COVID-19 Vaccine
Suspension injectable / 10 µg
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredDec 2021
COMIRNATY
Suspension injectable / 30 µg
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredMar 2021
Pfizer-BioNtech COVID-19 Vaccine
Suspension injectable / 30 µg
🇹🇳TunisiaBioNtech Manufacturing GmbHexpiredJan 2021

5 Capped MRNA Encoding Full Length SARS-COV-2 Spike Protein in Africa — Regulatory Overview

5 Capped MRNA Encoding Full Length SARS-COV-2 Spike Protein is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 0 (0%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.